A resurgence in COVID-19 cases is testing the endurance of health care workers who care for the sickest patients, most of whom are unvaccinated.

Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.

A ban on using telemedicine to prescribe controlled medications was suspended in the pandemic. That's allowed many to seek opioid addiction treatment, but some worry about potential for abuse.

Cutting the isolation for positive cases to five days could lead to more infections if people don't take masking seriously. A testing requirement would have made the policy safer, experts say.

Black patients and their families are less likely to sign up for end-of-life comfort care. To reach them, investors are starting hospice agencies run by people who look like the patients they serve.

A reporter's experience with COVID in his young family after a gathering of relatives could help you navigate the Christmas holidays.

The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.

The National Cancer Act became law 50 years ago. Cancer went from shameful taboo to one of the best-funded areas of medicine. Much of the credit for this transformation goes to one woman, Mary Lasker.

The National Cancer Act became law 50 years ago. Cancer went from shameful taboo to one of the best-funded areas of medicine. Much of the credit for this transformation goes to one woman, Mary Lasker.

New treatments for COVID-19 is expected to get Emergency Use Authorization from the Food and Drug Administration soon. But how much of the drug will be available, and how soon?

In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.

After baby Dorian Bennett arrived two months early and spent more than 50 days in the neonatal ICU, his parents received a bill of more than $550,000 — despite having health insurance.

Vaccines still do a solid job at warding off hospitalization from omicron. So if you're young and healthy, why get a booster? Scientists explain how boosters help and the best timing to get one.

Scott, a California native, was looking to help his patients who had eye disorders and discovered a way for the dangerous chemical to be used in medicine.

With Omicron surging, the U.K.'s government is hoping to stave off hospitalizations and deaths through a massive effort to administer vaccine boosters. But the strategy faces major hurdles in the U.S.